SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community
 
| More

TMCNet:  U.S. Patents Awarded to Inventors in California (Nov. 10)

[November 10, 2012]

U.S. Patents Awarded to Inventors in California (Nov. 10)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Nov. 10 -- The following federal patents were awarded to inventors in California.

*** Abbott Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Abbott Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,303,509) developed by William E. Webler, Escondido, Calif., and Mina Chow, Campbell, Calif., for an "echogenic needle catheter configured to produce an improved ultrasound image." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An echogenic medical device, such as a needle catheter, which produces an improved ultrasonic image of the device, and a method of performing a medical procedure using a device of the invention. One aspect is directed to a catheter which reduces artifacts in the ultrasound image of the catheter. In one embodiment, the catheter has a spherical distal tip. Another aspect of the invention is directed to an echogenic catheter with echogenic portions arranged in an array to facilitate determination by ultrasonic imaging of the rotational orientation of the catheter relative to a desired location within the patient." The patent application was filed on Sept. 14, 2010 (12/882,156). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,509.PN.&OS=PN/83,03,509&RS=PN/83,03,509 Written by Amal Ahmed; edited by Jaya Anand.



*** Onpharma Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Onpharma, Los Gatos, Calif., has been assigned a patent (8,303,566) developed by Matthew J. Stepovich, Santa Cruz, Calif., and Michael I. Falkel, Carmel Highlands, Calif., for "methods and apparatus for buffering parenteral solutions." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for transferring solutions from a first cartridge into a second cartridge comprises a cartridge holder, a plunger driver, and a cartridge connector. The cartridge connector carries a transfer needle and an exhaust needle. The cartridge holder positions the first cartridge against the cartridge connector so that the transfer needle penetrates the first cartridge septum. The second cartridge is removably inserted into another end of the cartridge connector so that both the transfer needle and the exhaust needle penetrate the second cartridge septum. The plunger driver is disposed to advance a plunger on the first cartridge to transfer solution from the first cartridge into the second cartridge thus displacing solution from the second cartridge through the exhaust needle. The cartridge connector includes a sealed interior waste chamber for receiving the solution from the second cartridge." The patent application was filed on July 9, 2010 (12/833,702). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,566.PN.&OS=PN/83,03,566&RS=PN/83,03,566 Written by Amal Ahmed; edited by Jaya Anand.

*** Pacesetter Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Pacesetter, Sylmar, Calif., has been assigned a patent (8,303,511) developed by four co-inventors for an "implantable pressure transducer system optimized for reduced thrombosis effect." The co-inventors are Neal L. Eigler, Pacific Palisades, Calif., Brian M. Mann, Marina Del Rey, Calif., James S. Whiting, Los Angeles, and Werner Hafelfinger, Thousand Oaks, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates generally to systems and methods for optimizing the performance and minimizing complications related to implanted sensors, such as pressure sensors, for the purposes of detecting, diagnosing and treating cardiovascular disease in a medical patient. Systems and methods for anchoring implanted sensors to various body structures are also provided." The patent application was filed on April 21, 2005 (11/111,691). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,511.PN.&OS=PN/83,03,511&RS=PN/83,03,511 Written by Amal Ahmed; edited by Jaya Anand.

*** Errorless Medical Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Errorless Medical, Seal Beach, Calif., has been assigned a patent (8,303,571) developed by Timothy Y. Kraushaar, Seal Beach, Calif., and Michael A. Merchant, Franklin, Mass., for "multiple-line connective devices for infusing medication." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A multiple-line connective device for use in a medication infusing system includes a connective device body forming a main flow passage from an inlet to an outlet along a longitudinal axis, the main flow passage including an interior surface having a raised surface feature configured to induce turbulent liquid flow through the main flow passage. One or more branches extend from the connective device body, each defining at least one branch passage in communication with the main flow passage. Each branch passage enters the main flow passage at an angle with respect to the longitudinal axis that imparts a flow through the branch passage that has a directional component that is parallel to the longitudinal axis and in the direction from the inlet to the outlet." The patent application was filed on July 30, 2010 (12/847,935). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,571.PN.&OS=PN/83,03,571&RS=PN/83,03,571 Written by Amal Ahmed; edited by Jaya Anand.

*** Microsoft Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Microsoft, Redmond, Wash., has been assigned a patent (8,306,049) developed by Eduardo S.C. Takahashi, Cupertino, Calif., for a "multicast subscription based on forward error correction." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments are disclosed herein that relate to multicast subscription based on forward error correction. One disclosed embodiment comprises a network-accessible server having a data-holding subsystem holding instructions executable by a logic subsystem to receive a content item, and form a first version of the content item having a first level of forward error correction and a second version of the content item having a second level of forward error correction. The instructions are further executable to stream the first version of the content item to a first multicast address, and while streaming the first version of the content item, stream the second version of the content item to a second multicast address." The patent application was filed on Feb. 22, 2010 (12/709,776). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,306,049&OS=8,306,049&RS=8,306,049 Written by Arpi Sharma; edited by Anand Kumar.

*** National Semiconductor Assigned Patent ALEXANDRIA, Va., Nov. 10 -- National Semiconductor, Santa Clara, Calif., has been assigned a patent (8,303,484) developed by four co-inventors for a "self-propelled robotic device that moves through bodily and other passageways." The co-inventors are Peter J. Hopper, San Jose, Calif., Philipp Lindorfer, San Jose, Calif., William French, San Jose, Calif., and Visvamohan Yegnashankaran, Cupertino, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A self-propelled robotic device moves through bodily and other passageways by inflating regions of an overlying bladder along the length of the robotic device in a sequence that imparts motion to the device. The regions of the overlying bladder are inflated by energizing a plurality of coils, which are surrounded by a ferrofluid, in a sequence. The ferrofluid responds to the magnetic field created by an energized coil by creating a bulge in the side wall of the overlying bladder." The patent application was filed on Nov. 19, 2009 (12/621,719). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,484.PN.&OS=PN/83,03,484&RS=PN/83,03,484 Written by Amal Ahmed; edited by Jaya Anand.

*** Dallen Medical Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Dallen Medical, San Clemente, Calif., has been assigned a patent (8,303,591) developed by Seth A. Foerster, San Clemente, Calif., for a "load shaping for dynamic tensioning mechanisms and methods." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A surgical tensioning device for dynamically holding two tissue portions in contact with one another comprises a resilient body having a plurality of spring elements, and a plurality of stop members for limiting travel of the spring elements in order to control energy stored or delivered by the spring elements. A length of suture is also provided, wherein a first end of the suture is connected to the resilient body at a first attachment point and a second end of the suture is connected to the resilient body at a second attachment point. In one embodiment, the stop members contact one another to limit compression of the spring elements. When the suture is placed in tension, the spring elements move to an extended configuration and the stop members move apart, creating gaps between ends of each of the stop members. When the gaps become sufficiently large, edges of the stop elements contact corresponding spring elements to impede further widening of the gaps and consequent further extension of the spring elements, thus protecting the springs." The patent application was filed on March 18, 2009 (12/406,904). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,591.PN.&OS=PN/83,03,591&RS=PN/83,03,591 Written by Amal Ahmed; edited by Jaya Anand.

*** Warsaw Orthopedic Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Warsaw Orthopedic, Warsaw, Ind., has been assigned a patent (8,303,496) developed by Adrian M. Nowitzke, Wilston, Australia, and Eric S. Heinz, Mountain View, Calif., for "instruments and methods for selective tissue retraction through a retractor sleeve." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and instruments for performing surgery in a patient are provided that minimize tissue dissection and retraction to access locations within the patient. One specific application concerns devices, instruments and techniques that provide for selective retraction of tissue, neural elements, organs or other anatomical structures at locations distally of the retractor sleeve providing percutaneous access to the locations." The patent application was filed on Sept. 9, 2008 (12/207,202). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,496.PN.&OS=PN/83,03,496&RS=PN/83,03,496 Written by Amal Ahmed; edited by Jaya Anand.

*** Evalve Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Evalve, Menlo Park, Calif., has been assigned a patent (8,303,608) developed by seven co-inventors for "fixation devices for variation in engagement of tissue." The co-inventors are Eric A. Goldfarb, San Francisco, Alfred H. Raschdorf, Kings Park, N.Y., Jaime E. Sarabia, San Jose, Calif., Sylvia Wen-Chin Fan, Burlingame, Calif., Kent D. Dell, Redwood City, Calif., Jan Komtebedde, Los Gatos, Calif., and Ferolyn T. Powell, San Francisco.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Devices, systems and methods are provided for tissue approximation and repair at treatment sites, particularly in those procedures requiring minimally-invasive or endovascular access to remote tissue locations. Fixation devices are provided to fix tissue in approximation with the use of distal elements. In some embodiments, the fixation devices have at least two distal elements and an actuatable feature wherein actuation of the feature varies a dimension of the at least two distal elements. In other embodiments, the fixation devices have at least two pairs of distal elements wherein the pairs of distal elements are moveable to engage tissue between opposed pairs of distal elements. Systems are also provided having fixation devices and accessories." The patent application was filed on Sept. 15, 2010 (12/883,013). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,608.PN.&OS=PN/83,03,608&RS=PN/83,03,608 Written by Amal Ahmed; edited by Jaya Anand.

*** Abbott Cardiovascular Systems Assigned Patent for Methods and Apparatuses for Image Guided Medical Procedures ALEXANDRIA, Va., Nov. 10 -- Abbott Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,303,505) developed by William E. Webler, Escondido, Calif., and Mina Chow, Campbell, Calif., for "methods and apparatuses for image guided medical procedures." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatuses for the image guidance and documentation of medical procedures. One embodiment includes combining small field of view images into a recorded image of with a large field of view and aligning the small field of view real time image with the recorded image through correlation of imaging data. A location and orientation determination system may be used to track the imaging system and provide a starting set of image alignment parameters and/or provide change updates to a set of image alignment parameters, which is then further improved through correlating imaging data. The recorded image may be selected according to real time measurement of a cardiac parameter during an image guided cardiac procedure. Image manipulations planned based on the recorded image can be stored and applied to the real time information. The position of the medical device may be determined and recorded through manipulating a cursor in a 3-D image space shown in two non-parallel views." The patent application was filed on Dec. 2, 2005 (11/293,559). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,505.PN.&OS=PN/83,03,505&RS=PN/83,03,505 Written by Amal Ahmed; edited by Jaya Anand.

*** Great Links G.B. Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Great Links G.B., Wilmington, Del., has been assigned a patent (8,306,053) developed by four co-inventors for "methods and apparatus for providing quality-of-service guarantees in computer networks." The co-inventors are Ronald D. Fellman, San Diego, Rene L. Cruz, San Diego, Douglas A. Palmer, San Diego, and Bart Schade, Solana Beach, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An arbitration mechanism provides quality of service guarantees for time-sensitive signals sharing a local area computer network with non-time-sensitive traffic. Device adapters are placed at all access points to an Ethernet network. The device adapters limit admission rates and control the timing of all packets entering the network. By doing so, collisions are eliminated for timesensitive traffic, thereby guaranteeing timely delivery. A common time reference is established for the device adapters. The time reference includes a frame with a plurality of phases. Each of the phases is assigned to a device adapter. Each device adapter is allowed to transmit packets of data onto the network only during the phase assigned thereto. The length of the phases may be modified in accordance with the number of packets to be transmitted by a particular device adapter. A master device adapter may be appointed to synchronize each of the device adapters." The patent application was filed on May 27, 2008 (12/127,250). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,306,053&OS=8,306,053&RS=8,306,053 Written by Arpi Sharma; edited by Anand Kumar.

*** NuVasive Assigned Patent ALEXANDRIA, Va., Nov. 10 -- NuVasive, San Diego, has been assigned a patent (8,303,515) developed by four co-inventors for a "surgical access system and related methods." The co-inventors are Patrick Miles, San Diego, Scot Martinelli, Mountain Top, Pa., Eric Finley, Poway, Calif., and Luiz Pimenta, Sao Paulo, Brazil.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A surgical access system including a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. Some embodiments of the surgical access system may be particularly suited for establishing an operative corridor to a surgical target site in the spine. Such an operative corridor may be established through the retroperitoneal space and the psoas muscle during a direct lateral, retroperitoneal approach to the spine." The patent application was filed on Dec. 11, 2009 (12/635,869). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,515.PN.&OS=PN/83,03,515&RS=PN/83,03,515 Written by Amal Ahmed; edited by Jaya Anand.

*** University of Southern California Assigned Patent ALEXANDRIA, Va., Nov. 10 -- The University of Southern California, Los Angeles, has been assigned a patent (8,306,047) developed by Joseph D. Touch, Manhattan Beach, Calif., Joseph Bannister, Palos Verdes Estates, Calif., and Stephen Suryaputra, Cary, N.C., for a "packet switch with separate look ahead, computation, and shift phases." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A packet switch architecture that can switch optical packets at high throughputs without using any random access memory, without fragmenting variable length packets into fixed length fragments and reassembling them, and without converting the optical packets into electronic packets. Programmable delay lines are use which delay the output of each packet for a programmable amount which may be re-programmed while the packet is being delayed by the programmable delay line. Programmable delay line controllers manages the delays imposed by the programmable delay lines so as to have a look-ahead phase during which information about the packets is gathered and a shift phase during which the sequence of packets is shifted to match an output sequence." The patent application was filed on July 28, 2010 (12/845,616). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,306,047&OS=8,306,047&RS=8,306,047 Written by Arpi Sharma; edited by Anand Kumar.

*** Microline Surgical Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Microline Surgical, Beverly, Mass., has been assigned a patent (8,303,585) developed by Kenneth H. Mollenauer, Saratoga, Calif., for a "combined dissecting, cauterizing, and stapling device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A medical device for simultaneously cutting tissue with a heating element, cauterizing the tissue with sealing elements, and stapling the tissue together. The heating elements comprise bipolar RF electrodes." The patent application was filed on July 8, 2008 (12/169,214). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,585.PN.&OS=PN/83,03,585&RS=PN/83,03,585 Written by Amal Ahmed; edited by Jaya Anand.

*** Baxano Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Baxano, San Jose, Calif., has been assigned a patent (8,303,516) developed by four co-inventors for a "method, system and apparatus for neural localization." The co-inventors are Gregory P. Schmitz, Los Gatos, Calif., Michael P. Wallace, Pleasanton, Calif., Jeffery L. Bleich, Palo Alto, Calif., and Eric C. Miller, Los Gatos, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are devices, systems and methods for determining if a nerve is nearby a device or a region of a device. In general, a device for determining if a nerve is nearby a device includes an elongate body having an outer surface with one or more bipole pairs arranged on the outer surface. Bipole pairs may also be referred to as tight bipoles. The bipole pairs may be arranged as a bipole network, and may include a cathode and an anode that are spaced relatively close together to form a limited broadcast field. In general, the broadcast filed is a controlled or "tight" broadcast field that extends from the bipole pair(s). Methods of using these devices and system are also described." The patent application was filed on April 20, 2011 (13/090,944). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,516.PN.&OS=PN/83,03,516&RS=PN/83,03,516 Written by Amal Ahmed; edited by Jaya Anand.

*** BlueSky Medical Group Assigned Patent ALEXANDRIA, Va., Nov. 10 -- BlueSky Medical Group, Memphis, Tenn., has been assigned a patent (8,303,552) developed by Richard Scott Weston, Encinitas, Calif., for a "reduced pressure wound treatment system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A reduced pressure treatment appliance is provided for treating a wound on the body of a patient. In some embodiments, the appliance comprises a cover, which can have a top cup member and an interface member. The interface member can have flow control means, configured to permit exudate from the wound to flow through the flow control means into the volume under the cover, but not in the opposite direction. Also, in some embodiments, the top cup member can have a lid member, a cup body member, and lid attachment means to removably attach the lid member to the cup body member. In some embodiments, the cover can be configured to facilitate access to the wound for monitoring, treatment and other purposes without removing the cover from the body. The wound treatment appliance can have a vacuum system to supply reduced pressure to the site of the wound in the volume under the cover. A suction bulb can be used to provide a source of reduced pressure to the cover. Additionally, methods are provided for using various embodiments of the treatment appliance." The patent application was filed on March 8, 2010 (12/719,715). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,552.PN.&OS=PN/83,03,552&RS=PN/83,03,552 Written by Amal Ahmed; edited by Jaya Anand.

*** K2M Assigned Patent for Minimal Incision Maximal Access MIS Spine Instrumentation and Method ALEXANDRIA, Va., Nov. 10 -- K2M, Leesburg, Va., has been assigned a patent (8,303,499) developed by James S. Hamada, Torrance, Calif., for a "minimal incision maximal access MIS spine instrumentation and method." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A surgical access device includes a frame defining an aperture, first and second support members mounted on the frame, and first and second retractor blades releasably coupled with the first and second support members, respectively. The first and second retractor blades each include a distal portion defining a recess having an arcuate profile, wherein the first and second retractor blades are movable between a close cooperative position and a spaced apart position with respect to each other." The patent application was filed on March 5, 2012 (13/412,106). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,499.PN.&OS=PN/83,03,499&RS=PN/83,03,499 Written by Amal Ahmed; edited by Jaya Anand.

*** Intel Assigned Patent for Method and System to Support Wireless Multicast Transmission ALEXANDRIA, Va., Nov. 10 -- Intel, Santa Clara, Calif., has been assigned a patent (8,306,055) developed by Michelle Gong, Sunnyvale, Calif., and Guoqing Li, Portland, Ore., for a "method and system to support wireless multicast transmission." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system may include a source station to provide wireless multicast transmission to a plurality of destination stations according to a protocol adaptation layer multicast management protocol. The protocol adaptation layer may lie above the MAC layer. The multicast management protocol includes formation, maintenance, and termination procedures. Other embodiments are described and claimed." The patent application was filed on Dec. 24, 2009 (12/647,179). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,306,055&OS=8,306,055&RS=8,306,055 Written by Arpi Sharma; edited by Anand Kumar.

*** AT&T Intellectual Property II Assigned Patent for Method and System of Monitoring the Receipt of Multicast Traffic ALEXANDRIA, Va., Nov. 10 -- AT&T Intellectual Property II, Atlanta, has been assigned a patent (8,306,043) developed by Lee Breslau, Basking Ridge, N.J., and William Fenner, Woodside, Calif., for a "method and system of monitoring the receipt of multicast traffic." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system for monitoring data packet traffic in a multicast network comprising determining a first packet count received at a receiver router, representing a quantity of data packets associated with a multicast group and source at a first time, determining a second packet count received at that receiver router representing a quantity of data packets associated with that multicast group and source, at a second time subsequent to the first time, comparing the second packet count to the first packet count, and indicating an alarm in response to the second packet count being less than a predetermined value greater than the first packet count. A status for multiple routers can be obtained, comprising a difference between the quantity of the first and second packet counts; and indicating a warning in response to at least one of the plurality of router status being less than the predetermined value." The patent application was filed on May 21, 2010 (12/784,878). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,306,043&OS=8,306,043&RS=8,306,043 Written by Arpi Sharma; edited by Anand Kumar.

*** Medtronic MiniMed Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Medtronic MiniMed, Northridge, Calif., has been assigned a patent (8,303,572) developed by Randy W. Adair, Valencia, Calif., Sheldon B. Moberg, Thousand Oaks, Calif., and Chalirmkiert Srisathapat, Sun Valley, Calif., for a medication reservoir.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus for a connection interface between a reservoir or syringe, infusion set tubing, and an infusion pump is provided. A base is provided which is adapted to receive a reservoir. The base has a base engagement member, such as a detent, projecting therefrom. A cap is provided which is adapted to receive the base. The cap includes a first cap engagement member, such as a detent opening, which is adapted to removably engage the base detent. The cap further includes a second cap detent opening which is adapted to removably engage the base detent. A piercing member, such as a needle, is disposed in the interior of the cap in such a manner that the needle is separated from the reservoir septum when the base detent is in the first cap detent opening, and the needle pierces the reservoir septum when the base detent is in the second cap detent opening. When the reservoir, the base and the cap are connected to form an integrated unit, this unit is then capable of being inserted and secured in the infusion pump housing." The patent application was filed on June 8, 2011 (13/155,641). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,572.PN.&OS=PN/83,03,572&RS=PN/83,03,572 Written by Amal Ahmed; edited by Jaya Anand.

*** Scimed Life Systems Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Scimed Life Systems, Maple Grove, Minn., has been assigned a patent (8,303,510) developed by Pei Jei Cao, Fremont, Calif., Jian R. Yuan, Hayward, Calif., and Richard Romley, Tracy, Calif., for a "medical imaging device having a forward looking flow detector." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention generally relates to medical devices, and more particularly to an improved medical imaging device. In one embodiment, an imaging device includes a drive shaft having proximal and distal ends received within the lumen; an imaging transducer coupled to the distal end of the drive shaft and positioned at the distal portion of the elongate member; and a flow detector coupled to the imaging transducer. The flow detector may include a forward facing ultrasound transducer configured to emit energy in the direction of the longitudinal axis of the imaging device and detect a Doppler shift in the received echoes. In the case where the imaging device is located in a vessel having blood flow, such information may be used to calculate the velocity of the blood flow. The imaging device may be configured to be located in a catheter or guidewire." The patent application was filed on July 1, 2005 (11/173,548). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,510.PN.&OS=PN/83,03,510&RS=PN/83,03,510 Written by Amal Ahmed; edited by Jaya Anand.

*** NuVasive Assigned Patent ALEXANDRIA, Va., Nov. 10 -- NuVasive, San Diego, has been assigned a patent (8,303,498) developed by eight co-inventors for a "surgical access system and related methods." The co-inventors are Patrick Miles, San Diego, Scot Martinelli, San Diego, Eric Finley, San Diego, James Gharib, San Diego, Allen Farquhar, San Diego, Norbert F. Kaula, San Diego, Jeffrey J. Blewett, San Diego, and Goretti Medeiros, Plantsville, Conn., The abstract of the patent published by the U.S. Patent and Trademark Office states: "A surgical access system including a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site." The patent application was filed on Feb. 18, 2011 (13/030,798). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,498.PN.&OS=PN/83,03,498&RS=PN/83,03,498 Written by Amal Ahmed; edited by Jaya Anand.

*** Invention Science Fund I Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Invention Science Fund I, Bellevue, Wash., has been assigned a patent (8,303,573) developed by eleven co-inventors for "medical or veterinary digestive tract utilization systems and methods." The co-inventors are Edward S. Boyden, Cambridge, Mass., Roderick A. Hyde, Redmond, Wash., Muriel Y. Ishikawa, Livermore, Calif., Jordin T. Kare, Seattle, Robert Langer, Newton, Mass., Eric C. Leuthardt, St. Louis, Md., Dennis J. Rivet, Portsmouth, Va., Michael A. Smith, Phoenix, Charles Whitmer, North Bend, Wash., Lowell L. Wood Jr., Bellevue, Wash., and Victoria Y. H. Wood, Livermore, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a "primary" material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more." The patent application was filed on Nov. 29, 2007 (11/998,849). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,573.PN.&OS=PN/83,03,573&RS=PN/83,03,573 Written by Amal Ahmed; edited by Jaya Anand.

*** Boston Scientific Scimed Assigned Patent for Medical Device Including Actuator ALEXANDRIA, Va., Nov. 10 -- Boston Scientific Scimed, Maple Grove, Minn., has been assigned a patent (8,303,520) developed by Ajitkumar B. Nair, Milpitas, Calif., and Alain F. Sadaka, Los Gatos, Calif., for a "medical device including actuator." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An actuating medical device and methods for making and using the same. The actuating medical device may include a proximal shaft portion having a distal end region, an actuating shaft portion attached to the distal end region, one or more actuating members coupled to or otherwise disposed adjacent the actuating shaft portion, and a distal shaft portion attached to the actuating shaft portion. The actuating shaft portion may include a shape memory material and may be adapted to shift between a first configuration and a second configuration. Using the actuating medical device may include positioning the actuating medical device in a blood vessel and shifting the actuating shaft portion between the first and second configurations." The patent application was filed on Aug. 25, 2008 (12/197,521). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,520.PN.&OS=PN/83,03,520&RS=PN/83,03,520 Written by Amal Ahmed; edited by Jaya Anand.

*** Sunstorm Research Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Sunstorm Research, Los Gatos, Calif., has been assigned a patent (8,303,536) developed by James R. Benson, Los Gatos, Calif., for an implantable delivery device.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to delivery devices and methods for providing more uniform delivery of agents such as drugs. In some embodiments, a delivery device is provided made of one or more implantable materials having predetermined agent-permeable and agent-impermeable regions and a reservoir containing one or more active agents, either alone or in an acceptable composition, as well as methods of administering one or more agents using such a device. Also provided are methods of equilibrating such devices, so that a steady state of agent delivery can be achieved at or soon after introduction of the device to its intended location of use. Methods of use of such devices to deliver an agent are also provided." The patent application was filed on Sept. 2, 2008 (12/675,970). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,03,536.PN.&OS=PN/83,03,536&RS=PN/83,03,536 Written by Amal Ahmed; edited by Jaya Anand.

*** Advanced Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Advanced Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,304,012) developed by six co-inventors for a "method for drying a stent." The co-inventors are Andrew McNiven, Clonmel, Ireland, Scott Huter, Temecula, Calif., Joycelyn J. Amick, Temecula, Calif., Joseph J. Eppert, Hemet, Calif., Thomas Esbeck, Murrieta, Calif., and Jason Van Sciver, Los Gatos, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Various embodiments of methods and devices for coating stents are described herein." The patent application was filed on May 4, 2006 (11/418,696). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,304,012.PN.&OS=PN/8,304,012&RS=PN/8,304,012 Written by Kusum Sangma; edited by Anand Kumar.

*** Nanosolar Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Nanosolar, San Jose, Calif., has been assigned a patent (8,304,019) developed by Karl Pichler, Santa Clara, Calif., for a "roll-to-roll atomic layer deposition method and system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Atomic layer deposition in a roll-to-roll manufacturing environment is disclosed. At least a portion of a substrate from a first roll is disposed in a chamber. A first atomic layer deposition (ALD) half reaction is performed on the portion of the substrate while the portion is within the chamber. A subsequent ALD half reaction may be performed on the same portion of the substrate to form a layer of material. Multiple ALD sequences may be performed by passing the substrate through a sequence of ALD reaction chambers or by passing the substrate through one or more ALD reaction chambers in a continuous loop." The patent application was filed on Feb. 19, 2004 (10/782,233). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,304,019.PN.&OS=PN/8,304,019&RS=PN/8,304,019 Written by Kusum Sangma; edited by Anand Kumar.

*** Angiotech Pharmaceuticals (US) Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Angiotech Pharmaceuticals (US), Seattle, has been assigned a patent (8,303,973) developed by four co-inventors for a "multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use." The co-inventors are George Y. Daniloff, Mountain View, Calif., Michael Huy Ngo, Santa Clara, Calif., Olof Mikael Trollsas, San Jose, Calif., David M. Gravett, Vancouver, Canada, and Philip M. Toleikis, Vancouver, Canada.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Multifunctional compounds are provided that readily crosslink in situ to provide crosslinked biomaterials. The multifunctional compounds contain a single component having at least three reactive functional groups thereon, with the functional groups selected so as to be non-reactive in an initial environment and inter-reactive in a modified environment. Reaction of a plurality of the multifunctional compounds results in a three-dimensional crosslinked matrix. In one embodiment, a first functional group is nucleophilic, a second functional group is electrophilic, and at least one additional functional group is nucleophilic or electrophilic. Methods for preparing and using the multifunctional compounds, and kits including the multifunctional compounds are also provided. Exemplary uses for the multifunctional compounds include tissue augmentation, biologically active agent delivery, bioadhesion, and prevention of adhesions following surgery or injury." The patent application was filed on Sept. 19, 2005 (11/575,484). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,303,973.PN.&OS=PN/8,303,973&RS=PN/8,303,973 Written by Kusum Sangma; edited by Anand Kumar.

*** Seattle Genetics Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Seattle Genetics, Bothell, Wash., has been assigned a patent (8,303,955) developed by Leonard G. Presta, San Francisco, Lori Y. O'Connell, Montara, Calif., and Svetlana O. Doronina, Snohomish, Wash., for a "humanized anti-CD40 antibodies and their methods of use." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are humanized anti-CD40 antibodies and antigen-binding fragments and methods for treating disease characterized by expression of CD40 antigen." The patent application was filed on May 26, 2006 (11/913,305). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,303,955.PN.&OS=PN/8,303,955&RS=PN/8,303,955 Written by Kusum Sangma; edited by Anand Kumar.

*** Advanced Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Advanced Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,303,972) developed by Eugene T. Michal, San Francisco, for a "hydrogel bioscaffoldings and biomedical device coatings." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Bioscaffoldings formed of hydrogels that are crosslinked in situ in an infarcted region of the heart (myocardium) by a Michael's addition reaction or by a disulfide bond formed by an oxidative process are described. Each of the bioscaffoldings described includes hyaluronan as one of the hydrogel components and the other component is selected from collagen, collagen-laminin, poly-l-lysine, and fibrin. The bioscaffolding may further include an alginate component. The bioscaffoldings may have biofunctional groups such as angiogenic factors and stem cell homing factors bound to the collagen, collagen-laminin, poly-l-lysine, or fibrinogen hydrogel component. In particular, the biofunctional groups may be PR11, PR39, VEGF, bFGF, a polyarginine/DNA plasmid complex, or a DNA/polyethyleneimine (PEI) complex. Additionally, the hydrogel components may be injected into the infarct region along with stem cells and microspheres containing stem cell homing factors. The bioscaffolding may be formed on a stent or a cardiac medical device." The patent application was filed on Feb. 23, 2006 (11/361,920). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,303,972.PN.&OS=PN/8,303,972&RS=PN/8,303,972 Written by Kusum Sangma; edited by Anand Kumar.

*** Baxter International Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Baxter International, Deerfield, Ill., and Baxter Healthcare, Glattpark (Optikon), Switzerland, have been assigned a patent (8,303,981) developed by six co-inventors for a "fragmented polymeric compositions and methods for their use." The co-inventors are Donald G. Wallace, Menlo Park, Calif., Cary J. Reich, Los Gatos, Calif., Narinder S. Shargill, Dublin, Calif., Felix Vega, San Francisco, A. Edward Osawa, San Francisco, and Zhen Qian-Wallis, Castro Valley, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Cross-linked hydrogels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such hydrogels preferably have no free aqueous phase and may be applied to target sites in a patient's body by extruding the hydrogel through an orifice at the target site. Alternatively, the hydrogels may be mechanically disrupted and used in implantable articles, such as breast implants. When used in vivo, the compositions are useful for controlled release drug delivery, for inhibiting post-surgical spinal and other tissue adhesions, for filling tissue divots, tissue tracts, body cavities, surgical defects, and the like." The patent application was filed on July 1, 2011 (13/174,963). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,303,981.PN.&OS=PN/8,303,981&RS=PN/8,303,981 Written by Kusum Sangma; edited by Anand Kumar.

*** Human Genome Sciences Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Human Genome Sciences, Rockville, Md., has been assigned a patent (8,303,951) developed by Guo-Liang Yu, Berkeley, Calif., Reinhard Ebner, Gaithersburg, Md., and Jian Ni, Germantown, Md., for a "neutrokine-alpha antibodies and methods of use thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to a Neutrokine-alpha antibody and a process for producing a Neutrokine-alpha antibody. The invention further relates to screening methods for identifying compounds that inhibit or enhance the action of Neutrokine-alpha. Also provided are diagnostic methods for detecting autoimmune disorders and therapeutic methods for treating autoimmune disorders using a Neutrokine-alpha antibody." The patent application was filed on Feb. 26, 2009 (12/393,693). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,303,951.PN.&OS=PN/8,303,951&RS=PN/8,303,951 Written by Kusum Sangma; edited by Anand Kumar.

*** C3 Jian Assigned Patent ALEXANDRIA, Va., Nov. 10 -- C3 Jian, Inglewood, Calif., has been assigned a patent (8,303,962) developed by six co-inventors for an "antibacterial and antifungal peptides." The co-inventors are Randal H. Eckert, Redondo Beach, Calif., Chris Kaplan, Los Angeles, Jian He, Los Angeles, Daniel K. Yarbrough, Los Angeles, Maxwell Anderson, Sequim, Wash., and Jee-Hyun Sim, Garden Grove, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention provides novel antimicrobial peptides and formulations thereof. The peptides and/or formulations are effective to kill or to inhibit the growth and/or proliferation of various bacteria, yeast, and fungi." The patent application was filed on Jan. 6, 2010 (12/683,188). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,303,962.PN.&OS=PN/8,303,962&RS=PN/8,303,962 Written by Kusum Sangma; edited by Anand Kumar.

*** Access Medical Systems Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Access Medical Systems, Palo Alto, Calif., has been assigned a patent (8,304,255) developed by Robert F. Zuk, Atherton, Calif., and Hong Tan, San Jose, Calif., for a immunoassay cuvettes.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed immunoassay cuvettes that comprise diffusely bound and non-diffusely bound reagents for carrying out an immunoassay. The reaction and detection are carried out in the immunoassay cuvette. The immunoassay cuvette comprises a transparent front wall, a back wall, side walls, a bottom, and a top opening. The back wall of the cuvette has a substantially planar surface made of a non-porous material and comprises a capture zone having reagents non-diffusedly bound and a signal reagent zone having reagents diffusedly bound." The patent application was filed on Feb. 11, 2009 (12/369,564). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,255&OS=8,304,255&RS=8,304,255 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Momenta Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Momenta Pharmaceuticals, Cambridge, Mass., has been assigned a patent (8,304,250) developed by four co-inventors for "multi-dimensional chromatographic methods for separating N-glycans." The co-inventors are Ian Christopher Parsons, Belmont, Mass., Ting Zheng, Sunnyvale, Calif., Nur Sibel Gunay, Chestnut Hill, Mass., and Carlos J. Bosques, Arlington, Mass.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A multi-dimensional chromatographic method for the separation of N-glycans. The method comprises providing a glycan preparation that includes at least one negatively charged N-glycan. The glycan preparation is then separated by anion-exchange chromatography and at least one secondary chromatographic technique." The patent application was filed on April 15, 2008 (12/595,937). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,250&OS=8,304,250&RS=8,304,250 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Poetic Genetics, Leland University Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Poetic Genetics, Burlingame, Calif., and the Leland University, Palo Alto, Calif., have been assigned a patent (8,304,233) developed by Michele P. Calos, Burlingame, Calif., for "methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The subject invention provides a unidirectional site-specific integration system for integrating a nucleic acid into the genome of a target cell. The provided system includes a site-specific integrating expression cassette (INTEC) vector, consisting of (a) a polynucleotide of interest operably linked to a promoter, (b) a single recombination site, and (c) a hybrid recombination site. In using the subject systems for site-specific integration, the INTEC vector and integrase are introduced into the target cell and the cell is maintained under conditions sufficient to provide for site-specific integration of the nucleic acid into the target cell genome via a recombination event mediated by the site-specific recombinase. Also provided are kits that include the subject systems. The subjects systems, methods and kits find use in a variety of different applications, several representative ones of which are described in detail as well." The patent application was filed on Aug. 4, 2005 (11/198,885). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,233&OS=8,304,233&RS=8,304,233 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** National Semiconductor Assigned Patent ALEXANDRIA, Va., Nov. 10 -- National Semiconductor, Santa Clara, Calif., has been assigned a patent (8,304,320) developed by Sandeep R. Bahl, Palo Alto, Calif., William D. French, San Jose, Calif., and Constantin Bulucea, Sunnyvale, Calif., for a "configuration and fabrication of semiconductor structure in which source and drain extensions of field-effect transistor are defined with different dopants." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An insulated-gate field-effect transistor (100) provided along an upper surface of a semiconductor body contains a pair of source/drain zones (240 and 242) laterally separated by a channel zone (244). A gate electrode (262) overlies a gate dielectric layer (260) above the channel zone. Each source/drain zone includes a main portion (240M or 242M) and a more lightly doped lateral extension (240E or 242E) laterally continuous with the main portion and extending laterally under the gate electrode. The lateral extensions, which terminate the channel zone along the upper semiconductor surface, are respectively largely defined by a pair of semiconductor dopants of different atomic weights. With the transistor being an asymmetric device, the source/drain zones constitute a source and a drain. The lateral extension of the source is then more lightly doped than, and defined with dopant of higher atomic weight, than the lateral extension of the drain." The patent application was filed on May 3, 2011 (13/100,192). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,320&OS=8,304,320&RS=8,304,320 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Children's Hospital and Research Center Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Children's Hospital and Research Center, Oakland, Calif., has been assigned a patent (8,304,245) developed by Franciscus Albertus Kuypers, El Cerritos, Calif., Won Chul Lee, Berkeley, Calif., and Albert P. Pisano, Danville, Calif., for a "microfluidic flow lysometer device, system and method." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides a device, system and method that enables a microfluidic flow lysometer cell analyzer. Using a population of suspended living cells. cell surface molecule detection reagents, and cell cytoplasm (or nuclear) molecule detection reagents, this microfluidic cell analyzer can rapidly analyze a population of cells by running them on a one-at-a-time basis through small capillary channels. The cell's morphology or surface markers are analyzed, then the cells are lysed, and the molecules present in the cell's cytoplasm or nuclear material are analyzed. Cell morphology is then analyzed as the cell surface molecules are correlated with the molecules present in the same cell's cytoplasm or nucleic acids, and this correlated cell population data is then presented to a user for interpretation. The invention also addresses issues such as device fouling, correction for experimental artifacts (incomplete cell lyis, variable cell debris volume effects), and inadequate data collection that hampered earlier efforts in this area." The patent application was filed on Nov. 2, 2007 (11/934,718). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,245&OS=8,304,245&RS=8,304,245 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** MaxPower Semiconductor Assigned Patent ALEXANDRIA, Va., Nov. 10 -- MaxPower Semiconductor, Santa Clara, Calif., has been assigned a patent (8,304,329) developed by Jun Zeng, Torrance, Calif., and Mohamed N. Darwish, Campbell, Calif., for "power device structures and methods." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Vertical power devices which include an insulated trench containing insulating material and a gate electrode, and related methods. A body region is positioned so that a voltage bias on the gate electrode will cause an inversion layer in the body region. A layer of permanent charge, at or near the sidewall of the trench, provides charge balancing for the space charge in the depleted semiconductor material during the OFF state. A conductive shield layer is positioned below the gate electrode in the insulating material, and reduces capacitive coupling between the gate and the lower part of the trench. This reduces switching losses. In other embodiments, a planar gate electrode controls horizontal carrier injection into the vertical conduction pathway along the trench, while a shield plate lies over the trench itself to reduce capacitive coupling." The patent application was filed on Nov. 25, 2009 (12/626,523). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,329&OS=8,304,329&RS=8,304,329 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Duke University Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Duke University, Durham, N.C., has been assigned a patent (8,304,222) developed by James Jefferson Smith, Durham, N.C., Derek Jantz, Durham, N.C., and Homme W. Hellinga, Durham, Calif., for a "rationally-designed meganucleases with altered sequence specificity and heterodimer formation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Rationally-designed LAGLIDADG meganucleases and methods of making such meganucleases are provided. In addition, methods are provided for using the meganucleases to generate recombinant cells and organisms having a desired DNA sequence inserted into a limited number of loci within the genome, as well as methods of gene therapy, for treatment of pathogenic infections, and for in vitro applications in diagnostics and research." The patent application was filed on April 26, 2012 (13/457,041). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,222&OS=8,304,222&RS=8,304,222 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Applied Materials Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Applied Materials, Santa Clara, Calif., has been assigned a patent (8,304,351) developed by four co-inventors for an "in-situ ozone cure for radical-component CVD." The co-inventors are Linlin Wang, Fremont, Calif., Abhijit Basu Mallick, Palo Alto, Calif., Nitin K. Ingle, San Jose, Calif., and Shankar Venkataraman, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods of forming a dielectric layer are described. The methods include the steps of mixing a silicon-containing precursor with a plasma effluent, and depositing a silicon-and-nitrogen-containing layer on a substrate. The silicon-and-nitrogen-containing layer is converted to a silicon-and-oxygen-containing layer by curing in an ozone-containing atmosphere in the same substrate processing region used for depositing the silicon-and-nitrogen-containing layer. Another silicon-and-nitrogen-containing layer may be deposited on the silicon-and-oxygen-containing layer and the stack of layers may again be cured in ozone all without removing the substrate from the substrate processing region. After an integral multiple of dep-cure cycles, the conversion of the stack of silicon-and-oxygen-containing layers may be annealed at a higher temperature in an oxygen-containing environment." The patent application was filed on Dec. 20, 2010 (12/972,711). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,351&OS=8,304,351&RS=8,304,351 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** National Semiconductor Assigned Patent for Configuration and Fabrication of Semiconductor Structure Having Bipolar Junction Transistor In Which Non-monocrystalline Semiconductor Spacing Portion Controls Base-link Length ALEXANDRIA, Va., Nov. 10 -- National Semiconductor, Santa Clara, Calif., has been assigned a patent (8,304,308) developed by Jeng-Jiun Yang, Sunnyvale, Calif., and Constantin Bulucea, Sunnyvale, Calif., for a "configuration and fabrication of semiconductor structure having bipolar junction transistor in which non-monocrystalline semiconductor spacing portion controls base-link length." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A semiconductor structure contains a bipolar transistor (101) and a spacing structure (265-1 or 265-2). The transistor has an emitter (241), a base (243), and a collector (245). The base is formed with an intrinsic base portion (243I), a base link portion (243L), and a base contact portion (245C). The intrinsic base portion is situated below the emitter and above material of the collector. The base link portion extends between the intrinsic base portion and the base contact portions. The spacing structure includes an isolating dielectric layer (267-1 or 267-2) and a spacing component. The dielectric layer extends along the upper semiconductor surface. The spacing component includes a lateral spacing portion (269-1 or 269-2) of largely non-monocrystalline semiconductor material, preferably polycrystalline semiconductor material, situated on the dielectric layer above the base link portion. Opposite first and second upper edges of the lateral spacing portion (275-1 and 277-1) laterally conform to opposite first and second lower edges (297-1 and 299-1) of the base link portion so as to determine, and thereby control, its length." The patent application was filed on Aug. 4, 2011 (13/198,601). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,308&OS=8,304,308&RS=8,304,308 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Danisco US Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Danisco US, Palo Alto, Calif., has been assigned a patent (8,304,221) developed by six co-inventors for a "regulatable growth of filamentous fungi." The co-inventors are Ali R. Akin, Berkeley, Calif., Elizabeth A. Bodie, San Carlos, Calif., Shirley M. Burrow, Preston, United Kingdom, Nigel Dunn-Coleman, Los Gatos, Calif., Geoffrey Turner, Sheffield, United Kingdom, and Michael Ward, San Francisco.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention generally relates to hyphal growth in fungi and in particular describes the modulation of genes associated with hyphal growth in filamentous fungi. The present invention provides methods and systems for the production of proteins and/or chemicals from filamentous fungi which comprise modulation of genes associated with hyphal growth. Specifically, the present invention is directed to a full length cotA gene, its gene product and methods of use." The patent application was filed on June 15, 2010 (12/816,362). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,221&OS=8,304,221&RS=8,304,221 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Chem Spectra Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Chem Spectra, Pleasanton, Calif., has been assigned a patent (8,304,251) developed by Jeffrey Haas, San Ramon, Calif., and Douglas Haas, Lancaster, Calif., for a "portable explosive or drug detection system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods are disclosed to automatically detect the presence of a substance on a test swipe by capturing a background image of the test swipe; applying one or more test chemicals to a test swipe; adjusting the temperature of the test swipe to a predetermined temperature range; capturing an in-situ image of the test swipe after the application of chemical at the predetermined temperature range; subtracting the background image from the in-situ image; generating a difference value from the two images; and searching a known database to identify the substance." The patent application was filed on Feb. 18, 2009 (12/388,490). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,304,251&OS=8,304,251&RS=8,304,251 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Phage Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Nov. 10 -- Phage Pharmaceuticals, San Diego, has been assigned a patent (8,304,219) developed by Robert Paul Levine, Palo Alto, Calif., for "kluyveromyces strains metabolizing cellulosic and hemicellulosic materials." The abstract of the patent published by the U.S. Patent and Trademark Office states: "This For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1105169 (c) 2012 Targeted News Service

[ Back To LatinAmerica.tmcnet.com's Homepage's Homepage ]






Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.